BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3509456)

  • 1. An assessment of ciprofloxacin per os in treatment of serious infections.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Beziau H
    Chemioterapia; 1987 Jun; 6(2 Suppl):391-4. PubMed ID: 3509456
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin versus placebo in the treatment of acute bacterial diarrhea.
    Pichler H; Diridl G; Stickler K; Wolf D
    Chemioterapia; 1987 Jun; 6(2 Suppl):490-1. PubMed ID: 3334608
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical use of ciprofloxacin: an interesting new oral antibiotic.
    Berman SJ
    Hawaii Med J; 1988 Apr; 47(4):162-4. PubMed ID: 3290154
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral ciprofloxacin for treatment of severe infections.
    Lobo IM; Silva NF; Assef MC; Mangini C; Silva ML; Bortoletto ML; Mendonça JS; Levi GC
    Int J Clin Pharmacol Res; 1993; 13(2):81-5. PubMed ID: 8354593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New specifics registered in Austria].
    Wien Klin Wochenschr; 1987 Sep; 99(18):655-63. PubMed ID: 3687025
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciprofloxacin in the treatment of complicated urinary tract infections.
    Naber K; Sörgel F
    Chemioterapia; 1987 Jun; 6(2 Suppl):522-3. PubMed ID: 3509488
    [No Abstract]   [Full Text] [Related]  

  • 7. Follow-up therapy with ciprofloxacin in severe infection, an alternative to parenteral treatment.
    Bassaris HP; Chrysanthopoulos CJ; Skouelis AT; Starakis JC
    J Chemother; 1989 Jul; 1(4 Suppl):676-7. PubMed ID: 16312588
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of urinary tract infections with ciprofloxacin].
    Horcicková M; Prát V; Matousovic K; Hatala M; Liska M; Milotová Z
    Cas Lek Cesk; 1987 Sep; 126(39):1221-4. PubMed ID: 3664597
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral ciprofloxacin in the treatment of 14 patients with bacterial pneumonia.
    Wollschlager CM; Raoof S; Khan FA
    N Y State J Med; 1987 Jun; 87(6):330-3. PubMed ID: 3475610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ciprofloxacin in the treatment of respiratory infections. Analysis of an Italian series].
    Maggiolo F; Bianchi W; Ohnmeiss H
    G Ital Chemioter; 1988; 35(1-3):39-44. PubMed ID: 3256511
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciprofloxacin: an overview and prospective appraisal.
    Neu HC
    Am J Med; 1987 Apr; 82(4A):395-404. PubMed ID: 3578329
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
    Scully BE; Jules K; Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of oral ciprofloxacin in pelvic inflammatory disease.
    De Wilde R
    J Chemother; 1989 Jul; 1(4 Suppl):896-7. PubMed ID: 16312693
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral ciprofloxacin for treatment of chronic osteomyelitis.
    Yamaguti A; Trevisanello C; Lobo IM; Carvalho MC; Bortoletto ML; Silva ML; Brasil Filho R; Levi GC; Mendonça JS
    Int J Clin Pharmacol Res; 1993; 13(2):75-9. PubMed ID: 8354592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity and clinical efficacy of ciprofloxacin in otorhinolaryngeal infections.
    Speciale A; Blandino G; Caccamo F; Serra A
    Drugs; 1995; 49 Suppl 2():403-5. PubMed ID: 8549378
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study.
    Ramirez-Ronda C; Saavedra S
    Chemioterapia; 1987 Jun; 6(2 Suppl):432-4. PubMed ID: 3334591
    [No Abstract]   [Full Text] [Related]  

  • 18. Ciprofloxacin treatment of acute infections in immunocompromised host.
    Nemes G; Heuser Y; Stolle D; Piroth HD; Nemes P
    J Chemother; 1989 Jul; 1(4 Suppl):722-3. PubMed ID: 16312607
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S; Galante D; Bianchi W; Gagliardi R
    Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
    Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.